TY - JOUR
T1 - An overview of “Chronic viral infection and cancer, openings for vaccines” virtual symposium of the TechVac Network - December 16-17, 2021
AU - Isaguliants, Maria G.
AU - Trotsenko, Ivan
AU - Buonaguro, Franco M.
N1 - Funding Information:
Publication is supported by the Program NAWA EUROPARTNER: Strengthening and spreading international partnership activities of the Faculty of Biology and Environmental Protection for interdisciplinary research and innovation of the University of Lodz and Virtual Mobility Grant of the European Network of Vaccine Adjuvants ENOVA COST Action CA16231 to MGI at Riga Stradins University, Riga, Latvia.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/7
Y1 - 2022/7
N2 - This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.
AB - This is a report on the research activities currently ongoing in virology, oncology and virus-associated cancers and possibilities of their treatment and prevention by vaccines and immunotherapies as outlined at the symposium “Chronic viral infection and cancer, openings for vaccines” virtually held on December 16–17, 2021. Experts from the various disciplines involved in the study of the complex relationships between solid tumors and viruses met to discuss recent developments in the field and to report their personal contributions to the specified topics. Secondary end point was to sustain the TECHVAC Network established in 2016 as a multidisciplinary work group specifically devoted to development of vaccines and immunotherapies against chronic viral infections and associated cancers, with the aim to identify areas of common interest, promote research cooperation, establish collaborative cross-border programs and projects, and to coordinate clinical and research activities.
UR - http://www.scopus.com/inward/record.url?scp=85133720148&partnerID=8YFLogxK
U2 - 10.1186/s13027-022-00436-0
DO - 10.1186/s13027-022-00436-0
M3 - Article
C2 - 35804391
AN - SCOPUS:85133720148
SN - 1750-9378
VL - 17
SP - 28
JO - Infectious Agents and Cancer
JF - Infectious Agents and Cancer
IS - Suppl 2
M1 - 28
T2 - Chronic viral infections and Cancer, openings for vaccines
Y2 - 16 December 2021 through 17 December 2021
ER -
